News

The British Medical Association (BMA) has called for the Office of Fair Trading (OFT) to extend its private healthcare market review to include insurers' fee schedules.

Medical insurance brokers have branded Defacto's new private medical insurance (PMI) star ratings as ‘highly dangerous and not in the best interest of customers'.

Axa PPP has extended its cancer coverage to include the clinically effective prostate cancer drug rejected for the NHS because it is too expensive.

The government looks set to force through its controversial welfare reforms without giving the House of Lords a chance to readdress the amendments it made.

Cancer charities have slammed the National Institute for Health and Clinical Excellence's (Nice) decision to reject a drug that prolongs the life of prostate cancer suffers for being too expensive.

Brits would rather insure pets than themselves or their families, a survey has found.

Zurich has revealed it paid 92% of critical illness (CI) claims last year.

Defaqto has released its Star Ratings for private medical insurance (PMI) for the first time.

Government ministers will aim to overturn the exclusion of means-testing of cancer patients receiving Employment and Support Allowance (ESA) as the coalition's government's Welfare Reform Bill moves back to the House of Commons.

Absence management procedures have not kept pace with technology and the way Britain works, resulting in serious welfare, management and productivity issues, a new report has said.